Technologies – ACBRD

Out in the OPEN: trialing open-source automated insulin delivery in type 1 diabetes

As open-source artificial pancreas systems gain traction, we feature the first multi-centre trial published in New England Journal of Medicine

A recent study asked parents of young children with type 1 diabetes about their experiences using a hybrid closed-loop system

We recently attended and presented work at the American Diabetes Association 82nd Scientific Sessions in New Orleans

The acceptability of ‘Laura’ in the ‘My Diabetes Coach’ app

A University of Michigan study shows that what people think about hypoglycaemia matters, even if they are using the latest diabetes technologies

The ACBRD was involved in testing the benefit of the My Diabetes Coach (MDC) program

Researchers at the ACBRD interviewed people with type 1 diabetes to hear about their experiences

The ACBRD co-authored a Diabetes Care publication on the outcomes of a randomised controlled trial with Hybrid Closed Loop systems

The ACBRD is collaborating with an international group to research the impact of open-source artificial pancreas systems

New insights from the HypoCOMPaSS trial published in Diabetes Care